Home524816 • BOM
add
Natco Pharma Ltd
Previous close
₹1,124.45
Day range
₹1,100.00 - ₹1,134.90
Year range
₹752.10 - ₹1,134.90
Market cap
197.80B INR
Avg Volume
117.93K
P/E ratio
12.70
Dividend yield
0.45%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 6.47B | 36.33% |
Operating expense | 4.02B | 0.37% |
Net income | 1.52B | 13.91% |
Net profit margin | 23.40 | -16.46% |
Earnings per share | 8.46 | 13.86% |
EBITDA | 1.57B | 326.63% |
Effective tax rate | 12.03% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 32.04B | 30.08% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 86.54B | — |
Shares outstanding | 179.08M | — |
Price to book | 2.33 | — |
Return on assets | — | — |
Return on capital | 3.15% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 1.52B | 13.91% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad, Telangana. It develops, manufactures and markets finished dosage formulations, active pharmaceutical ingredients, and agrochemical products for domestic and international markets. The company describes itself as vertically integrated and has export presence in more than 50 countries. Natco focuses on complex generic products and limited-competition molecules. Wikipedia
Founded
1981
Headquarters
Website
Employees
4,199
